期刊文献+

促进眼用制剂角膜渗透性的研究进展 被引量:4

Research progress on improving the corneal permeability of ophthalmic preparations
原文传递
导出
摘要 为促进眼用制剂的角膜渗透性提供方案参考。通过检索国内外的相关文献,对促进眼用制剂角膜透过性的各类方法展开综述。药物的角膜渗透性是决定眼用制剂生物利用度的主要因素。目前,较为行之有效的改善眼用制剂角膜渗透性的方法就是添加角膜渗透促进剂和应用新技术来制备各类眼用制剂。 To provide referenced plans for improving the corneal permeability of ophthalmic preparations. To summarize the methods of improving the corneal permeability of ophthalmic preparations by retrieving domestic and abroad literature. Its bioavailability depends on the corneal permeability of drugs. At present, adding corneal penetrating promoter and applying the new technologies to prepare various kinds of ophthalmic preparations are the effective means to improve the corneal permeability of ophthalmic preparations.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2014年第14期1227-1231,共5页 Chinese Journal of Hospital Pharmacy
基金 福建省科技计划重点项目(编号:2008Y0058)
关键词 眼用制剂 生物利用度 角膜渗透促进剂 制剂新技术 ophthalmic preparations bioavailability corneal penetrating promoter preparation technologies
  • 相关文献

参考文献34

二级参考文献358

共引文献92

同被引文献26

  • 1唐跃年,刘海涛,李方,胡燕峰.双波长法测定复方地塞米松滴眼液中地塞米松的含量[J].药学服务与研究,2004,4(4):389-390. 被引量:1
  • 2姚毅,张卯年,刘玉凤,王瑛,杨丙建.迪立舒和典必殊滴眼液对白内障超声乳化手术后抗炎疗效的比较观察[J].中华医院感染学杂志,2007,17(1):35-37. 被引量:8
  • 3LV Xiaoyan, LI Jing, ZHANG Ming, et al. Enhancement of sodium caprate on intestine absorption and antidiabetic action of berberine [ J ]. AAPS Pharm Sci Tech, 2010, 11 ( 1 ) : 372-382.
  • 4UCHIYAMA T, SUGIYAMA T, QUAN Y S, et al. Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: the intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-β-D-mahopyanoside [ J ]. J Pharm Phaimacol, 1999,51 : 1241-1250.
  • 5AL-Halafi AM. Nanoearriers of nanotechnology in retinal dis- eases[J]. Saudi J Ophthalmol, 2014, 28(4): 304-309.
  • 6Adijanto J, Naash MI. Nanopartiele-based technologies for retinal gene therapy[J]. Eur J Pharm Biopharm, 2015, 95 (B) ; 353-367.
  • 7Myles ME, Neumann DM, Hill JM. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transseleral iontophoresis[J]. Adv Drug Deliv Rev, 2005, 57 (14) : 2063-2079.
  • 8Thrimawithana TR, Young S, Bunt CR, et al. Drug delivery to the posterior segment of the eye[J].Drug Diseov Today, 2011, 16(5/6) : 270-277.
  • 9Geroski DH, Edelhauser HF. Transscleral drug delivery for posterior segment disease[J]. Adv Drug Deliv Rev, 2001, 52 (1) : 37-48.
  • 10Kaur IP,Kakkar S. Nanotherapy for posterior eye diseases [J]. J Control Release, 2014, 193(10): 100-112.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部